Hostname: page-component-84b7d79bbc-4hvwz Total loading time: 0 Render date: 2024-07-25T13:43:34.415Z Has data issue: false hasContentIssue false

Poliomyelitis surveillance in England and Wales, 1969–1975

Published online by Cambridge University Press:  15 May 2009

J. W. G. Smith
Affiliation:
Epidemiological Research Laboratory, Central Public Health Laboratory, Colindale Avenue, LondonNW9 5HT
P. J. Wherry
Affiliation:
Epidemiological Research Laboratory, Central Public Health Laboratory, Colindale Avenue, LondonNW9 5HT
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Poliomyelitis continued to be a rare disease in England and Wales in the period 1969–75. Only 31 paralytic and 44 cases of possible non-paralytic poliomyelitis were recorded during the 7 years.

Of the 31 paralytic cases approximately one third were vaccine-associated; 3 were patients who had recently received oral poliovaccine and 7 had been in contact with a vaccinated person. Five of these 7 patients were parents of recently vaccinated children. The rate of vaccine-associated poliomyelitis was estimated in recipients to be 0·2 and in contacts 0·4 per million doses of vaccine given.

Marker test results were reported on 555 strains of poliomyelitis virus isolated during 1969–75, using the reproductive capacity temperature test. Forty-eight (8·6%) resembled wild virus in this property, 15 strains being type 1, 8 type 2 and 25 type 3. Most of these isolations of apparently wild virus were from excreters with no symptoms of poliomyelitis, although 3 of the 15 type 1 strains were from patients with paralytic poliomyelitis and 3 from possible cases of non-paralytic poliomyelitis. None of the 8 apparently wild type 2 viruses was from a case of paralytic illness and only 1 of the 39 type 3 strains.

Eleven of the 31 paralytic cases were in patients in whom the infection was likely to have been acquired abroad.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1978

References

REFERENCES

Cossart, Y. E. (1967). Genetic marker studies of poliovirus. 1. Natural variation. Journal of Hygiene 65, 77.Google Scholar
D.H.S.S. (1972). Immunisation against infectious diseases. Department of Health and Social Security.Google Scholar
Galbraith, N. S. (1963). Poliomyelitis surveillance in England and Wales, 1962. In Proceedings of the Ninth Symposium of the European Association against Poliomyelitis and Allied Diseases, Stockholm, p. 92. Brussels: AEP.Google Scholar
Geffen, T. J. (1960). Poliomyelitis in vaccinated subjects. England and Wales, 1959. Monthly Bulletin of the Ministry of Health and the Public Health Laboratory Service 19, 196.Google ScholarPubMed
Geffen, T. J. & Spicer, C. C. (1960). Poliomyelitis in the vaccinated. England and Wales, 1958. Lancet ii, 87.Google Scholar
Haward, R. A. (1973). Scale of undernotification of infectious diseases by general practitioners. Lancet i, 873.Google Scholar
Henderson, D. A., Witte, J. J., Morris, L. & Langmuir, A. D. (1964). Paralytic disease associated with oral polio vaccines. Journal of the American Medical Association 190, 41.Google Scholar
Miller, D. L. (1970). Poliomyelitis in England and Wales, 1965–1969. In Proceedings of an International Conference on the Application of Vaccines against Viral, Rickettsial and Bacterial Diseases of Man, Washington, D.C., p. 190. Pan American Health Organization Scientific Publication no. 226, 1971.Google Scholar
Miller, D. L. & Galbraith, N. S. (1965). Surveillance of the safety of oral poliomyelitis vaccine in England and Wales, 1962–4. British Medical Journal ii, 504.CrossRefGoogle Scholar
Miller, D. L., Reid, D. & Diamond, J. R. (1970). Poliomyelitis surveillance in England and Wales, 1965–8. Public Health, London 89, 265.Google Scholar
Report (1976). The relationship between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry. Bulletin of the World Health Organization 53, 319.Google Scholar
Roden, A. T. (1964). Surveillance of Salk vaccination in England and Wales, 1956–61. Proceedings of the Royal Society of Medicine 57, 464.CrossRefGoogle ScholarPubMed
Schonberger, L. B., McGowan, J. E. Jr & Gregg, M. B. (1976). Vaccine-associated poliomyelitis in the United States, 1961–1972. American Journal of Epidemiology 104, 202.Google Scholar
Smith, J. W. G., Lee, J. A., Fletcher, W. B., Morris, C. A., Parker, D. A., Yetts, R., Magrath, D. I. & Perkins, F. T. (1976). The response to oral poliovaccine in persons aged 16–18 years. Journal of Hygiene 76, 235.Google Scholar